HROW · Healthcare · $1.1B
$30.80-1.91%
What's this stock's score right now?
See its score for free — revenue and money flow, graded on one standard.
Quarterly Financials
9/'26
6/'26 vs prev quarter
Among 60 Drug Manufacturers - Specialty & Generic peers
Quarterly Revenue Growth
“2분기 매출 7,070만 달러는 1분기 4,400만 달러에서 약 60% 반등했지만, 2025년 4분기 8,900만 달러에는 아직 못 미쳐요.”
In the company's words · 2026 2분기 earnings call